Levy Adam D.

1.3

4.2

4.4

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Acrivon Therapeutics Inc (ACRV)

Transaction date 4 Aug 2026

Sale

Price

131.54

Quantity 32,631 +19.5%

Value US$3,078,882

Comments Filing

Acrivon Therapeutics Inc (ACRV)

Transaction date 14 Jan 2026

Purchase

Price

80.22

Quantity 61,701 +15.3%

Value US$2,175,974

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-08-06	2026-08-04	Acrivon Therapeutics Inc (ACRV)	S Sale	32,631 +19.5% 131.54 US$3,078,882	32,631 +19.5%	131.54	US$3,078,882
2026-01-16	2026-01-14	Acrivon Therapeutics Inc (ACRV)	B Purchase	61,701 +15.3% 80.22 US$2,175,974	61,701 +15.3%	80.22	US$2,175,974